Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

China flag China · Delayed Price · Currency is CNY
9.12
+0.18 (2.01%)
Jun 27, 2025, 3:00 PM CST
42.95%
Market Cap 2.99B
Revenue (ttm) 746.90M
Net Income (ttm) 213.81M
Shares Out 327.30M
EPS (ttm) 0.65
PE Ratio 14.04
Forward PE n/a
Dividend 0.25 (2.74%)
Ex-Dividend Date Jun 18, 2025
Volume 4,874,910
Average Volume 5,994,497
Open 8.94
Previous Close 8.94
Day's Range 8.92 - 9.14
52-Week Range 5.91 - 9.95
Beta 0.11
RSI 48.96
Earnings Date Aug 21, 2025

About SHA:603811

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, capsules, tablets, pharmaceutical intermediates in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Shanghai, China. [Read more]

Sector Healthcare
Founded 1966
Employees 637
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603811
Full Company Profile

Financial Performance

In 2024, SHA:603811's revenue was 714.37 million, an increase of 6.36% compared to the previous year's 671.63 million. Earnings were 200.70 million, an increase of 23.21%.

Financial Statements

News

There is no news available yet.